IART Q1 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$357M+38.1% YoY

Gross Profit

$213M59.6% margin

Operating Income

$26M7.2% margin

Net Income

$11M3.1% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

-3.1%

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

$26M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.8B

Stockholders' Equity

$998M

Cash & Equivalents

$189M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$357M	$259M	+38.1%
Gross Profit	$213M	$172M	+23.7%
Operating Income	$26M	$10M	+156.8%
Net Income	$11M	$6M	+71.9%

Revenue Segments

Codman Specialty Surgical

$236M66%

Orthopedics and Tissue Technologies

$121M34%

Geographic Segments

UNITED STATES

$249M70%

Europe

$52M14%

Asia Pacific

$36M10%

Rest Of World

$21M6%